NCT04945096 Outcomes of Patients After Allo-HSCT With Decitabine and NAC Status NOT_YET_RECRUITING Phase PHASE3
NCT03945591 High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Status COMPLETED Phase PHASE2
NCT03851601 Immuno-regulatory Profiling of T Cells in GVHD Treated With Extracorporeal Photopheresis Status COMPLETED Phase N/A
NCT03763318 A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD Status COMPLETED Phase PHASE1/PHASE2
NCT03680092 Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT03605927 CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease Status COMPLETED Phase PHASE1
NCT03459040 A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD Status COMPLETED Phase PHASE2
NCT03233659 Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Status COMPLETED Phase N/A
NCT03188601 α1-antitrypsin (AAT) Levels and Functions in Allogeneic Bone Marrow Transplantation and Throughout Progression Into GVHD Status COMPLETED Phase N/A
NCT02942173 CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT Status COMPLETED Phase PHASE2/PHASE3
NCT02891603 A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression Status COMPLETED Phase PHASE1/PHASE2
NCT02712762 Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) Patients Status COMPLETED Phase N/A
NCT02588339 Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention Status COMPLETED Phase PHASE2
NCT02490163 Comparison of Two Automated Mononuclear Collection Systems in Patients Undergoing Extracorporeal Photochemotherapy. A Cross-over Equivalence Study. (MNC_CMNC) Status COMPLETED Phase PHASE3
NCT02441075 70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014 Status COMPLETED Phase NA
NCT02338232 Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation Status TERMINATED Phase NA
NCT02156479 Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients Status COMPLETED Phase N/A